Not only do mitochondria serve as the engine of the cell – they also act as watchtowers for the immune system.
Get the latest international news and world events from around the world.
Are we living inside a massive brain?
The human brain contains 86 billion neurons forming trillions of connections, giving rise to consciousness through complex interaction. On a vastly larger scale, the observable universe contains trillions of galaxies linked by cosmic filaments stretching tens of millions of light-years. Striking similarities between neural networks and the cosmic web raise a profound question: if awareness can emerge from complexity in the brain, what might emerge from complexity on a cosmic scale?
Venus may have swallowed its own moon
Venus may have once had a moon, but new research suggests the planet’s incredibly slow rotation could have doomed it. Computer simulations showed that instead of gradually drifting away like Earth’s moon, a Venusian moon would likely spiral inward until it crashed into the planet, with larger moons falling even faster.
Dark energy could be fading — and it might drag the entire Universe down with it
Cosmologists are reeling after new evidence has suggested the Universe’s rate of expansion is slowing, upturning theories about the future.
NASA smashed into an asteroid. Now Hera has revealed a strange new world
A European spacecraft has revealed a mysterious, crater-covered side of the asteroid Didymos as it prepares to investigate the aftermath of NASA’s historic 2022 asteroid impact. The mission could uncover new clues about the collision and help turn asteroid deflection into a powerful defense against future threats to Earth.
There could be trillions of tonnes of dark matter near the Moon, experts say
Although there’s evidence that dark matter forms vast halos around galaxies and clusters, while being sparse in enormous ‘voids’, there’s no reason to suppose dark matter doesn’t also exist on or around Earth.
In fact, one study suggests there are 24 trillion metric tonnes of dark matter lying between Earth and the Moon! Whether this is true or not is yet to be determined.
Breast cancer can outsmart treatment. Scientists may know how to stop it
Researchers were surprised by the strongest responses in breast cancer models that more closely mimic human disease.
Unseen details of human brain structure revealed
A detailed map of all the cells and connections in a single cubic millimeter of the human brain revealed previously unseen aspects of brain structure.
Could planets that orbit other stars be nonspherical?
Rich Livitski Seal Beach, California
Bodies large enough to be considered planets have enough mass that gravity molds them into a roughly spherical shape.
The key word here is roughly — other factors also come into play, such as a planet’s composition (rocky or gassy) and its rate of spin. The faster a planet spins, the more its rotation causes it to bulge outward at the equator. That’s because as a planet rotates, there’s a tug-of-war between the way material wants to fly off the planet due to rotation and the way gravity wants to pull all that planet’s material inward. The battle between these forces is most intense at the equator.
EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
The two essential requirements for pathologic specimens in the era of personalized therapies for non-small cell lung carcinoma (NSCLC) are accurate subtyping as adenocarcinoma (ADC) versus squamous cell carcinoma (SqCC) and suitability for EGFR molecular testing, as well as for testing of other oncogenes such as EML4-ALK and KRAS. Actually, the value of EGFR expressed in patients with NSCLC in predicting a benefit in terms of survival from treatment with an epidermal growth factor receptor targeted therapy is still in debate, while there is a convincing evidence on the predictive role of the EGFR mutational status with regard to the response to tyrosine kinase inhibitors (TKIs).
This is a literature overview on the state-of-the-art of EGFR oncogenic mutation in NSCLC. It is designed to highlight the preclinical rationale driving the molecular footprint assessment, the progressive development of a specific pharmacological treatment and the best method to identify those NSCLC who would most likely benefit from treatment with EGFR-targeted therapy. This is supported by the belief that a rationale for the prioritization of specific regimens based on patient-tailored therapy could be closer than commonly expected.








